Stocks · US
IBRX
XNAS
ImmunityBio, Inc. Common Stock
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-06 basis
P/E—
P/B—
P/S66.35x
EPS$-0.94
ROE94.81%
ROA-157.89%
Dividend yield0.00%
Debt/Equity-0.40
Free cash flow$-288M
Returns and 52-week range
1W+9.74%
1M+19.93%
3M+10.11%
6M+41.25%
1Y+281.50%
YTD+379.70%
52W high$12.43
52W low$1.95
From 52W high-22.04%
Company
Peers in the same sector
| Company | Market cap | P/E | P/B | 1M |
|---|---|---|---|---|
| BioMarin Pharmaceuticals Inc | $11.1B | 152.64 | 1.76 | -15.50% |
| Vaxcyte, Inc. Common Stock | $11.0B | — | 3.98 | +9.06% |
| Elanco Animal Health Incorporated Common Stock | $11.2B | — | 1.71 | -8.24% |
| 쿠퍼 | $10.8B | 18.93 | 1.30 | -18.91% |
| Bio-Techne Corp. | $11.4B | 62.59 | 5.40 | +0.00% |
| Repligen Corp | $10.7B | 257.46 | 5.06 | +4.33% |
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.